<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-BVTDVOAH</identifier><date>2013</date><creator>Frlan, Rok</creator><relation>documents/doc/B/URN_NBN_SI_doc-BVTDVOAH_001.htm</relation><relation>documents/doc/B/URN_NBN_SI_doc-BVTDVOAH_001.pdf</relation><relation>documents/doc/B/URN_NBN_SI_doc-BVTDVOAH_001.txt</relation><format format_type="issue">3</format><format format_type="volume">64</format><format format_type="type">article</format><format format_type="extent">str. 218-226</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">3501169</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-BVTDVOAH</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="eng">Helicobacter pylori</subject><subject language_type_id="slv">peptična razjeda</subject><subject language_type_id="slv">sečni kamni</subject><subject language_type_id="slv">ureaze</subject><subject language_type_id="slv">zaviralci</subject><title>Urease inhibitors</title><title>Zaviralci ureaze</title></Record>